Aptamers Market Analysis By Types (Nucleic Acid & Peptide), By Application (Diagnostics, Therapeutics, Research & Developments, Others), By Region, And Segment Forecasts, 2014 - 2025

Published: Jun, 2017 | Pages: 75 | Publisher: Grand View Research
Industry: Biotechnology | Report Format: Electronic (PDF)

The global aptamers market is expected to reach USD 8.91 billion by 2025 according to a new report by Grand View Research, Inc. Advancements in aptamer development technologies, increasing R&D, and rising number of companies investing in this market are some of the key driving factors responsible for the growth of this market.

Numerous advantages offered by these small molecules in comparison to established antibodies have also led to higher demand for these molecules across a diverse range of medical applications. They are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. Along with this, continuous advancement in technologies is expected to stimulate growth. Integrated DNA Technologies, Inc. introduced a next-generation product, Ultramers that contain aptamer template length up to 200 bases. According to the company, this new product will be apt for biotechnology applications such as gene and clone construction. Thus, new developments in this field are expected to boost usage of these products in different application areas, thereby driving market growth.

Furthermore, growing incidence of life-threatening diseases such as cancer has directed many companies to introduce new & effective detection assays based on aptamer therapy. In March 2017, Aptamer Sciences, Inc. unveiled multiprotein biomarker assay by using this technology for the detection of lung cancer. This kit is designed for early detection and diagnosis of non-small cell lung cancer by identifying a suitable biomarker. Such types of new product launches are expected to trigger the acceptance of these therapies, leading to market growth to a great extent. In addition, increasing number of small-scale startups, government organizations, rising number of products under clinical investigation, and growing number of academic research laboratories investigating the potential of aptamers are anticipated to support future growth of this market.

In contrast, many aptamers have failed to meet the requisite safety and efficacy standards in clinical studies. Thus, companies have to terminate the clinical investigation during late-stage clinical studies. This factor is likely to affect growth of this market negatively. In addition, other factors such as low awareness about these technologies in middle- & low-income countries and inadequate regulatory structure may hamper the overall growth.

Further key findings from the report suggest:

• The nucleic acid aptamer segment held majority of the revenue share in 2016 due to rise in demand for nucleic acid-based diagnostic kits and therapeutics across the globe

• Diagnostics application dominated the application segment in 2016 due to introduction of novel diagnostic kits by key players

• Developed regions such as North America and Europe dominated the global market due to growing demand for aptamer therapeutics coupled with rise in number of research laboratories

• Some of the key players include Aptamer Group; Aptamer Sciences, Inc.; Aptagen, LLC; Base Pair Biotechnologies, Inc.; Ophthotech Corporation; and others

 Table of Contents

Chapter 1 Research Methodology
                1.1 Information Procurement
                    1.1.1 Purchased database:
                    1.1.2 GVR's Internal Database
                1.2 Primary Research:
                    1.2.1 List of primary sources include:
Chapter 2 Executive Summary
                2.1 Market Snapshot
Chapter 3 Aptamers Market Variables, Trends & Scope
                3.1 Market Segmentation & Scope
                3.2 Market Driver Analysis
                    3.2.1 High advantage of aptamers compared to antibodies
                    3.2.2 Advancements in the field of aptamer development technologies
                    3.2.3 Growing interest of many companies to invest in aptamers market
                    3.2.4 Promising pipeline therapeutics
                3.3 Market Restraint Analysis
                    3.3.1 Rising number of setbacks of aptamer therapeutics in late stage clinical studies
                    3.3.2 Low awareness level and incomplete regulatory policies slow down the market growth
                3.4 Key Opportunity Prioritized
                3.5 Aptamers Market - SWOT Analysis, by Factor (political & legal, economic and technological)
                3.6 Industry Analysis - Porter's
Chapter 4 Aptamers Market: Types Estimates & Trend Analysis
                4.1 Aptamers Market: Types Movement Analysis
                4.2 Nucleic Acid Aptamers
                    4.2.1 Nucleic acid aptamers market estimates and forecasts, 2014 - 2025 (USD Million)
                4.3 Peptide Aptamers
                    4.3.1 Peptide aptamers market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 5 Aptamers Market: Application Estimates & Trend Analysis
                5.1 Aptamers Market: Application Movement Analysis
                5.2 Diagnostics (Biomarker Detection and Discovery and Molecular Imaging)
                    5.2.1 Diagnostics application market estimates and forecasts, 2014 - 2025 (USD Million)
                5.3 Therapeutics
                    5.3.1 Therapeutics application market estimates and forecasts, 2014 - 2025 (USD Million)
                5.4 Research and Development
                    5.4.1 Research and development application market estimates and forecasts, 2014 - 2025 (USD Million)
                5.5 Others (Biosensor, Food Safety Testing, Chemical Assay and Other)
                    5.5.1 Others application market estimates and forecasts, 2014 - 2025 (USD Million)
Chapter 6 Aptamers Market: Regional Estimates & Trend Analysis by Types and Application
                6.1 Aptamers Market Share, by Region, 2015 & 2025
                6.2 North America
                    6.2.1 North America aptamers market estimates and forecasts, by type 2014 - 2025 (USD Million)
                    6.2.2 North America aptamers market estimates and forecasts, by application 2014 - 2025 (USD Million)
                    6.2.3 U.S.
                        6.2.3.1 U.S. aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                        6.2.3.2 U.S. aptamers market estimates and forecasts by application, 2014 - 2025 (USD Million)
                    6.2.4 Canada
                        6.2.4.1 Canada aptamers market estimates and forecasts by type 2014 - 2025 (USD Million)
                        6.2.4.2 Canada aptamers market estimates and forecasts by application 2014 - 2025 (USD Million)
                6.3 Europe
                    6.3.1 Europe aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                    6.3.2 Europe aptamers market estimates and forecasts, by application 2014 - 2025 (USD Million)
                    6.3.3 Germany
                        6.3.3.1 Germany aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                        6.3.3.2 Germany aptamers market estimates and forecasts by application, 2014 - 2025 (USD Million)
                    6.3.4 UK
                        6.3.4.1 UK aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                        6.3.4.2 UK aptamers market estimates and forecasts by application, 2014 - 2025 (USD Million)
                6.4 Asia Pacific
                    6.4.1 Asia Pacific aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                    6.4.2 Asia Pacific aptamers market estimates and forecasts, by application 2014 - 2025 (USD Million)
                    6.4.3 Japan
                        6.4.3.1 Japan aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                        6.4.3.2 Japan aptamers market estimates and forecasts by application, 2014 - 2025 (USD Million)
                    6.4.4 China
                        6.4.4.1 China aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                        6.4.4.2 China aptamers market estimates and forecasts by application, 2014 - 2025 (USD Million)
                6.5 Latin America
                    6.5.1 Latin America aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                    6.5.2 Latin America aptamers market estimates and forecasts by application, 2014 - 2025 (USD Million)
                    6.5.3 Brazil
                        6.5.3.1 Brazil aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                        6.5.3.2 Brazil aptamers market estimates and forecasts by application, 2014 - 2025 (USD Million)
                    6.5.4 Mexico
                        6.5.4.1 Mexico aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                        6.5.4.2 Mexico aptamers market estimates and forecasts by application, 2014 - 2025 (USD Million)
                6.6 Middle East and Africa
                    6.6.1 Middle East and Africa aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                    6.6.2 Middle East and Africa aptamers market estimates and forecasts, by application 2014 - 2025 (USD Million)
                    6.6.3 South Africa
                        6.6.3.1 South Africa aptamers market estimates and forecasts by type, 2014 - 2025 (USD Million)
                        6.6.3.1 South Africa aptamers market estimates and forecasts by application, 2014 - 2025 (USD Million)
Chapter 7 Competitive Landscape
                7.1 Company Profiles
                    7.1.1 Ophthotech Corporation
                        7.1.1.1 Company overview
                        7.1.1.2 Financial performance
                        7.1.1.3 Product benchmarking
                        7.1.1.4 Strategic initiatives
                    7.1.2 SomaLogic, Inc.
                        7.1.2.1 Company overview
                        7.1.2.2 Financial performance
                        7.1.2.3 Product benchmarking
                        7.1.2.4 Strategic initiatives
                    7.1.3 Aptamer Group
                        7.1.3.1 Company overview
                        7.1.3.2 Product benchmarking
                        7.1.3.3 Strategic initiatives
                    7.1.4 Aptamer Sciences, Inc.
                        7.1.4.1 Company overview
                        7.1.4.2 Product benchmarking
                        7.1.4.3 Strategic initiatives
                    7.1.5 Base Pair Biotechnologies, Inc.
                        7.1.5.1 Company overview
                        7.1.5.2 Financial performance
                        7.1.5.3 Product benchmarking
                        7.1.5.4 Strategic initiatives
                    7.1.6 NOXXON Pharma
                        7.1.6.1 Company overview
                        7.1.6.2 Financial performance
                        7.1.6.3 Product benchmarking
                        7.1.6.4 Strategic initiatives
                    7.1.7 Vivonics Inc.
                        7.1.7.1 Company overview
                        7.1.7.2 Financial performance
                        7.1.7.3 Product benchmarking
                        7.1.7.4 Strategic initiatives
                    7.1.8 Aptagen, LLC
                        7.1.8.1 Company overview
                        7.1.8.2 Financial performance
                        7.1.8.3 Product benchmarking
                        7.1.8.4 Strategic initiatives
                    7.1.9 TriLink BioTechnologies, LLC
                        7.1.9.1 Company overview
                        7.1.9.2 Financial performance
                        7.1.9.3 Product benchmarking
                        7.1.9.4 Strategic initiatives

List of Tables

TABLE 1 Key Difference between Antibody and Aptamers
TABLE 2 North America aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 3 North America aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 4 U.S. aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 5 U.S. aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 6 Canada aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 7 Canada aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 8 Europe aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 9 Europe aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 10 Germany aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 11 Germany aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 12 UK aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 13 UK aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 14 Asia Pacific aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 15 Asia Pacific aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 16 Japan aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 17 Japan aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 18 China aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 19 China aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 20 Latin America aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 21 Latin America aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 22 Brazil aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 23 Brazil aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 24 Mexico aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 25 Mexico aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 26 Middle East and Africa aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 27 Middle East and Africa aptamers market, by application, 2014 - 2025 (USD Million)
TABLE 28 South Africa aptamers market, by types, 2014 - 2025 (USD Million)
TABLE 29 South Africa aptamers market, by application, 2014 - 2025 (USD Million)